Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Korea University
Sponsor:
Information provided by (Responsible Party):
K. M. Choi, Korea University
ClinicalTrials.gov Identifier:
NCT01594710
First received: April 28, 2012
Last updated: April 8, 2014
Last verified: April 2014
  Purpose

In Asia, the prevalence of metabolic syndrome have been dramatically increased. Therefore, the investigators intend to the collect the blood sample, laboratory, anthropometric, and body composition parameters prospectively to examine the risk factors of metabolic syndrome. Furthermore, the investigators will collect the data of carotid IMT and branchial ankle pulse wave velocity to clarify the metabolic risk factors of atherosclerosis.


Condition
Metabolic Syndrome, Atherosclerosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Korea University:

Primary Outcome Measures:
  • The impact of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) for developing metabolic syndrome in prospective design [ Time Frame: 36months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The relationship of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) with metabolic syndrome and atherosclerosis measured by baPWV and carotid IMT in cross sectional design [ Time Frame: 36months ] [ Designated as safety issue: No ]

Estimated Enrollment: 1000
Study Start Date: February 2012
Estimated Study Completion Date: May 2015
Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Apparently Health People

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Apparently healthy people who underwent medical routine check up in Korea University Helath Promotion Center.

Criteria

Inclusion Criteria:

  • Apparently healthy people who underwent medical routine check up in Korea Health Promotion Center.
  • age > 20 years

Exclusion Criteria:

  • History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
  • Stage 2 hypertension
  • Severe renal or hepatic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01594710

Contacts
Contact: Hye Jin Yoo, MD.Ph.D 822-2626-3045 deisy21@naver.com
Contact: Kyung Mook Choi, MD.Ph.D 822-2626-3043 medica7@gmail.com

Locations
Korea, Republic of
Korea University Guro Hospital Recruiting
Seoul, Korea, Republic of
Contact: Hye Jin Yoo, MD.Ph.D    822-2626-3045    deisy21@naver.com   
Contact: Kyung Mook Choi, MD.Ph.D    822-2626-3043    medica7@gmail.com   
Sponsors and Collaborators
Korea University
  More Information

No publications provided by Korea University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: K. M. Choi, Professor, Korea University
ClinicalTrials.gov Identifier: NCT01594710     History of Changes
Other Study ID Numbers: KoreaHealth_MS
Study First Received: April 28, 2012
Last Updated: April 8, 2014
Health Authority: South Korea: Institutional Review Board

Additional relevant MeSH terms:
Atherosclerosis
Arteriosclerosis
Metabolic Syndrome X
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 21, 2014